Qualitative or quantitative defects of desmin

Qualitative or quantitative defects of desmin (also known as desminopathy or desmin-related myopathy) refers to a group of rare disorders caused by mutations in the DES gene, which encodes desmin, the major intermediate filament protein in skeletal, cardiac, and smooth muscle. Desmin plays a critical role in maintaining the structural and mechanical integrity of muscle cells by connecting myofibrils to each other, to the sarcolemma, and to the nucleus. When desmin is abnormal (qualitative defect) or present in reduced amounts (quantitative defect), muscle cells become structurally compromised, leading to progressive muscle weakness and degeneration. The clinical presentation of desminopathy is variable but typically involves progressive skeletal myopathy, often beginning in the distal limb muscles before spreading proximally. Cardiac involvement is a hallmark feature and may include dilated or restrictive cardiomyopathy, conduction defects, arrhythmias, and heart failure, which can be life-threatening. Some patients also develop respiratory insufficiency due to diaphragmatic weakness. A characteristic pathological finding is the accumulation of desmin-positive aggregates within muscle fibers. Onset is most commonly in adulthood, though childhood and juvenile presentations have been reported. There is currently no cure or disease-specific therapy for desminopathy. Management is supportive and multidisciplinary, focusing on monitoring and treating cardiac complications (including pacemaker or implantable cardioverter-defibrillator placement when indicated), physical therapy for skeletal muscle weakness, and respiratory support as needed. Cardiac transplantation may be considered in severe cases of cardiomyopathy. Genetic counseling is recommended for affected individuals and their families.

Common questions about Qualitative or quantitative defects of desmin